Literature DB >> 1374811

Disulfide-bonded discontinuous epitopes on the glycoprotein of vesicular stomatitis virus (New Jersey serotype).

P R Grigera1, W Keil, R R Wagner.   

Abstract

Intrachain disulfide bonds between paired cysteines in the glycoprotein (G) of vesicular stomatitis virus (VSV) are required for the recognition of discontinuous epitopes by specific monoclonal antibodies (MAbs) (W. Keil and R. R. Wagner, Virology 170:392-407, 1989). Cleavage by Staphylococcus aureus V8 protease of the 517-amino-acid VSV-New Jersey G protein, limited to the glutamic acid at residue 110, resulted in a protein (designated GV8) with greatly retarded migration by polyacrylamide gel electrophoresis (PAGE) under nonreducing conditions. By Western blot (immunoblot) analysis, protein GV8 was found to lose discontinuous epitope IV, which maps within the first 193 NH2-terminal amino acids. These data, coupled with those obtained by PAGE migration of a vector-expressed, truncated protein (G1-193) under reducing and nonreducing conditions, lead us to postulate the existence of a major loop structure within the first 193 NH2-terminal amino acids of the G protein, possibly anchored by a disulfide bond between cysteine 108 and cysteine 169, encompassing epitope IV. Site-directed mutants in which 10 of the 12 cysteines were individually converted to serines in vaccinia virus-based vectors expressing these single-site mutant G proteins were also constructed, each of which was then tested by immunoprecipitation for its capacity to recognize epitope-specific MAbs. These results showed that mutations in NH2-terminal cysteines 130, 174, and, to a lesser extent, 193 all resulted in the loss of neutralization epitope VIII. A mutation at NH2-terminal cysteine 130 also resulted in the loss of neutralization epitope VII, as did a mutation at cysteine 108 to a lesser extent. Both epitopes VII and VIII disappeared when mutations were made in COOH-distal cysteine 235, 240, or 273, the general map locations of epitopes VII and VIII. These studies also reveal that distal, as well as proximal, cysteine residues markedly influence the disulfide-bond secondary structure, which ostensibly determines the conformational structure of the VSV-New Jersey G protein required for presentation of the major discontinuous epitopes recognized by neutralizing MAbs.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1374811      PMCID: PMC241160     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Reconstitution into liposomes of the glycoprotein of vesicular stomatitis virus by detergent dialysis.

Authors:  W A Petri; R R Wagner
Journal:  J Biol Chem       Date:  1979-06-10       Impact factor: 5.157

Review 2.  Epitopes on protein antigens: misconceptions and realities.

Authors:  W G Laver; G M Air; R G Webster; S J Smith-Gill
Journal:  Cell       Date:  1990-05-18       Impact factor: 41.582

3.  Effect of glycosylation on the conformational epitopes of the glycoprotein of vesicular stomatitis virus (New Jersey serotype).

Authors:  P R Grigera; M E Mathieu; R R Wagner
Journal:  Virology       Date:  1991-01       Impact factor: 3.616

4.  Restitution of infectivity to spikeless vesicular stomatitis virus by solubilized viral components.

Authors:  D H Bishop; P Repik; J F Obijeski; N F Moore; R R Wagner
Journal:  J Virol       Date:  1975-07       Impact factor: 5.103

5.  Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

Authors:  T R Fuerst; E G Niles; F W Studier; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

6.  Spontaneous mutations leading to antigenic variations in the glycoproteins of vesicular stomatitis virus field isolates.

Authors:  L Z Luo; Y Li; R M Snyder; R R Wagner
Journal:  Virology       Date:  1990-01       Impact factor: 3.616

7.  High-sensitivity sequencing with a gas-phase sequenator.

Authors:  M W Hunkapiller; R M Hewick; W J Dreyer; L E Hood
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

8.  Nucleotide sequence of a cDNA clone encoding the entire glycoprotein from the New Jersey serotype of vesicular stomatitis virus.

Authors:  C J Gallione; J K Rose
Journal:  J Virol       Date:  1983-04       Impact factor: 5.103

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Oligonucleotide-directed mutagenesis using M13-derived vectors: an efficient and general procedure for the production of point mutations in any fragment of DNA.

Authors:  M J Zoller; M Smith
Journal:  Nucleic Acids Res       Date:  1982-10-25       Impact factor: 16.971

View more
  3 in total

1.  Immunogenicity of an aphthovirus chimera of the glycoprotein of vesicular stomatitis virus.

Authors:  P R Grigera; M Garcia-Briones; O Periolo; J L la Torre; R R Wagner
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

2.  Stable expression of a novel fusion peptide of thioredoxin-1 and ABAD-inhibiting peptide protects PC12 cells from intracellular amyloid-beta.

Authors:  Xin Yang; Yu Yang; Jiang Wu; Jie Zhu
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

3.  Characterization of intramolecular disulfide bonds and secondary modifications of the glycoprotein from viral hemorrhagic septicemia virus, a fish rhabdovirus.

Authors:  K Einer-Jensen; T N Krogh; P Roepstorff; N Lorenzen
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.